C.M. Bidwell & Associates »

Rigel Pharmaceuticals shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9k 115 42.83
2025-09-30 $3.3k 115 28.33

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Vanguard Total Stock Market ETF (VTI)
Vanguard Malvern Fds strm infproidx (VTIP)
iShares Russell 2000 Index (IWM)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Schwab Strategic Tr sht tm us tres (SCHO)
iShares S&P 500 Index (IVV)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
Schwab Strategic Tr 0 (SCHP)
Dimensional Etf Trust (DFAC)
Schwab U S Broad Market ETF (SCHB)

View all positions for C.M. Bidwell & Associates

Top funds holding Rigel Pharmaceuticals

BlackRock
State Street Corporation
Vanguard Group
Armistice Capital
Goldman Sachs Group
Marshall Wace
Capitolis Liquid Global Markets
LSV Asset Management
Renaissance Technologies
Acadian Asset Management
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Jane Street
D. E. Shaw & Co
Soleus Capital Management

View all funds holding Rigel Pharmaceuticals